ArticleFrontiers in veterinary science2026
Management practices and continuing education in the treatment of canine idiopathic epilepsy among Indian primary care veterinarians.
Article in Frontiers in veterinary science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: In India and countries without veterinary neurologists, dogs with idiopathic epilepsy (IE) are managed by primary care veterinarians. Data are lacking on their practice patterns. Objectives: Describe management of canine IE among Indian primary care veterinarians and explore the impact of access to educational materials about epilepsy. Methods: Prospective, two-phased, survey-based study of Indian veterinarians focused on treatment and monitoring of canine IE and perceived confidence in management recommendations (1/not comfortable to 5/very comfortable). Participants who agreed to Phase II received concise guidelines about IE with a follow-up survey distributed after 6 months. Descriptive statistics summarized management trends and compared confidence scores between surveys. Results: 187 veterinarians participated in Phase I and of these, 36 participated in Phase II. Phenobarbital was the most common anti-seizure drug prescribed, chosen mostly due to efficacy. Most respondents (118/187; 63%) recommended routine lab work and (84/187; 45%) recommended measuring phenobarbital or potassium bromide blood concentration every 6-12 months; (61/187; 33%) reported not measuring blood concentrations routinely. Long-term management of IE and adverse effects of medications were rated as most challenging. Nearly half of Phase II respondents (17/36; 47%) ranked the educational materials as extremely beneficial. Mean self-reported comfort level was 3.3 (SD 0.97) and 3.69 (SD 0.89) for Phase I and II, respectively; most (20/36; 56%) reported no change between surveys. Conclusion: Challenges for Indian veterinarians in the chronic management of canine IE related to anti-seizure drug monitoring and adverse effects. Exploratory Phase II findings identified positive reception to educational support from specialists.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.